I'm a 16 years old korean trader who started with 10k now got $100
Daytrading futures, forex, stocks, etc.
Is it valid strategy?
Daytrading futures, forex, stocks, etc.
Is price possibly goes up above 4.10(acquisition price)??
Checkpoint Therapeutics is a clinical stage immuno oncology biopharmaceutical that focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302.
What should I trade to maximize profit in short-term??
Daytrading futures, forex, stocks, etc.
I'm 16years old Korean investor and not sure about my future
Daytrading futures, forex, stocks, etc.
what do yo guys thought on ckpt now
Checkpoint Therapeutics is a clinical stage immuno oncology biopharmaceutical that focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302.
Im not sure ckpt will be offered any deal.
Checkpoint Therapeutics is a clinical stage immuno oncology biopharmaceutical that focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302.
ckpt what it means? plz explain
Checkpoint Therapeutics is a clinical stage immuno oncology biopharmaceutical that focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302.
what tools do you use for profitable and much more insight?(advice plz)
You have found the place. We don't moderate (much). Enjoy actual free discussion.
DD ckpt why i think stock will 10x and it should be 10x
Checkpoint Therapeutics is a clinical stage immuno oncology biopharmaceutical that focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302.
ckpt Time to 10x your money! look into it.
Like 4chan found $5. Ever wanted to learn how to trade options AND share your progress with people online, but you're too poor for WSB? If so, you've come to the right place.
CKPT : The best opportunity to win 10x your money
A place to lose money with friends and likewise degenerates. The posts and advice here should be taken with caution, this is not financial advice.
CKPT risk factors in commercialization and my strategy
Checkpoint Therapeutics is a clinical stage immuno oncology biopharmaceutical that focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302.
The possible scenario of commercialization FDA new approved drug by ckpt
Checkpoint Therapeutics is a clinical stage immuno oncology biopharmaceutical that focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302.
what is wrong with ckpt
Checkpoint Therapeutics is a clinical stage immuno oncology biopharmaceutical that focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302.
